M Serke

Summary

Affiliation: HELIOS Klinikum Wuppertal
Country: Germany

Publications

  1. ncbi request reprint [Multimodal therapy of small cell and non-small cell lung carcinoma]
    M Serke
    Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
    Dtsch Med Wochenschr 132:1221-4. 2007
  2. ncbi request reprint [Diagnosis and staging of lung cancer]
    M Serke
    Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
    Dtsch Med Wochenschr 132:1165-9. 2007
  3. ncbi request reprint [Therapeutic options in malignant pleural mesothelioma]
    M Serke
    HELIOS Klinikum Emil von Behring, Lungenklinik Heckeshorn, Zentrum fur Pneumologie und Thoraxchirurgie
    Pneumologie 59:337-48. 2005
  4. ncbi request reprint [Combined alternating radiochemotherapy in stage III (TNM) (limited disease) small cell bronchial carcinoma: a phase II study with carboplatin/etoposide/vincristine and alternating radiotherapy]
    M Serke
    Lungenklinik Heckeshorn, Pneumologie II, Berlin
    Pneumologie 53:485-92. 1999
  5. doi request reprint A 62-year-old woman with bilateral pleural effusions and pulmonary infiltrates caused by extramedullary hematopoiesis
    C Schwarz
    Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Deutschland
    Respiration 78:110-3. 2009
  6. ncbi request reprint [Modern endoscopic procedures for diseases of the respiratory tract]
    N Schonfeld
    Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
    Dtsch Med Wochenschr 132:2633-6. 2007
  7. ncbi request reprint [Pharmacologic treatment of bronchial cancer. Part 1: Standards]
    M Serke
    Zentrum fur Pneumologie und Thoraxchirurgie, Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
    Pneumologie 60:493-508. 2006
  8. ncbi request reprint [Bronchial carcinoma in young adults]
    N Schonfeld
    Pneumologische Abt II, Lungenklinik Heckeshorn, Berlin
    Pneumologie 53:480-4. 1999
  9. ncbi request reprint [High frequency diathermy--a new method in the treatment of malignant and benign stenosis of the airways]
    N Schonfeld
    Lungenklinik Heckeshorn, Berlin
    Pneumologie 53:477-9. 1999
  10. ncbi request reprint [Lung cancer: targeted therapy]
    M Serke
    HELIOS Klinikum Emil von Behring, Lungenklinik Heckeshorn, Pneumologie, Berlin
    Pneumologie 61:162-70. 2007

Collaborators

Detail Information

Publications15

  1. ncbi request reprint [Multimodal therapy of small cell and non-small cell lung carcinoma]
    M Serke
    Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
    Dtsch Med Wochenschr 132:1221-4. 2007
    ..Second line therapy has become standard and targeted therapies are under evaluation and are common in second line chemotherapy...
  2. ncbi request reprint [Diagnosis and staging of lung cancer]
    M Serke
    Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany
    Dtsch Med Wochenschr 132:1165-9. 2007
    ..Internistic thoracoscopy or video assisted thoracoscopic surgery (VATS) may be used in malignant pleural effusions. Mediastinoscopy staging is the gold-standard for mediastinal staging...
  3. ncbi request reprint [Therapeutic options in malignant pleural mesothelioma]
    M Serke
    HELIOS Klinikum Emil von Behring, Lungenklinik Heckeshorn, Zentrum fur Pneumologie und Thoraxchirurgie
    Pneumologie 59:337-48. 2005
    ..Radiotherapy may be applied in case of local tumour growth. The individual therapeutic decision will depend on tumour stage, concomitant diseases, performance status, and on the patient's preference...
  4. ncbi request reprint [Combined alternating radiochemotherapy in stage III (TNM) (limited disease) small cell bronchial carcinoma: a phase II study with carboplatin/etoposide/vincristine and alternating radiotherapy]
    M Serke
    Lungenklinik Heckeshorn, Pneumologie II, Berlin
    Pneumologie 53:485-92. 1999
    ..Response rate and 2-year survival are promising. Local and systemic failure is an ongoing problem and requires better local and systemic control of the disease...
  5. doi request reprint A 62-year-old woman with bilateral pleural effusions and pulmonary infiltrates caused by extramedullary hematopoiesis
    C Schwarz
    Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Deutschland
    Respiration 78:110-3. 2009
    ..The definite diagnosis was established by pleuroscopy followed by successful pleurodesis with talc slurry, after tetracycline pleurodesis had failed...
  6. ncbi request reprint [Modern endoscopic procedures for diseases of the respiratory tract]
    N Schonfeld
    Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
    Dtsch Med Wochenschr 132:2633-6. 2007
    ..The procedure does not only provide a definite diagnosis for almost all of the patients, it also allows the immediate option for talcum poudrage in case of pleural malignancy...
  7. ncbi request reprint [Pharmacologic treatment of bronchial cancer. Part 1: Standards]
    M Serke
    Zentrum fur Pneumologie und Thoraxchirurgie, Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin
    Pneumologie 60:493-508. 2006
    ..In the second part single drugs are described with their typical effects and side effects from the viewpoint of a clinician. A following part II will discuss new "targeted" biologicals...
  8. ncbi request reprint [Bronchial carcinoma in young adults]
    N Schonfeld
    Pneumologische Abt II, Lungenklinik Heckeshorn, Berlin
    Pneumologie 53:480-4. 1999
    ..314 patients). We conclude that lung cancer presents a clearly different clinical picture in younger patients but not a better prognosis...
  9. ncbi request reprint [High frequency diathermy--a new method in the treatment of malignant and benign stenosis of the airways]
    N Schonfeld
    Lungenklinik Heckeshorn, Berlin
    Pneumologie 53:477-9. 1999
    ..In conclusion, high-frequency electrocautery is an effective and safe method for endobronchial resection and can be considered a good alternative to the laser as the classical method for endobronchial resection...
  10. ncbi request reprint [Lung cancer: targeted therapy]
    M Serke
    HELIOS Klinikum Emil von Behring, Lungenklinik Heckeshorn, Pneumologie, Berlin
    Pneumologie 61:162-70. 2007
    ..There are ongoing studies with targeted therapies in all stages of lung cancer. Major advances of these new drugs are their low toxicity and, in part, the oral application...
  11. ncbi request reprint [Adjuvant chemotherapy in non-small-cell lung cancer: proven survival benefit]
    M Serke
    Pneumologie II, Lungenklinik Heckeshorn, Zentralklinik Emil von Behring, Berlin
    Pneumologie 58:393-4. 2004
  12. ncbi request reprint [Recommendations on the therapy of bronchial carcinoma]
    M Thomas
    Klinik für Hämatologie, Onkologie und Pneumologie, Medizinische Klinik A, Universitatsklinikum Munster, Germany
    Pneumologie 56:113-31. 2002
  13. ncbi request reprint [Non-small-cell bronchial carcinoma with pathological N2 involvement: adjuvant radiotherapy versus adjuvant chemo-radiotherapy]
    M Serke
    , Zentralklinik Emil von Behring, Dept. Lungenklinik Heckeshorn, Zum Heckeshorn 33, 14109 Berlin
    Kongressbd Dtsch Ges Chir Kongr 118:606-10. 2001
    ..Comparing the two groups there was an advantage (not significant) in favor of the combined treated group with a median survival of 1449 days versus 765 days (p = 0.22)...
  14. ncbi request reprint [Multimodality therapy concept in stage I-IIIA small cell bronchial carcinoma. Case follow-up over 15 years]
    E Allica
    Zentralklinik Emil von Behring, Department Lungenklinik Heckeshorn, Zum Heckeshorn 33, 14109 Berlin
    Kongressbd Dtsch Ges Chir Kongr 118:596-600. 2001
    ..A median survival of 22.4 months in multimodally treated LD-SCLC, most of them stage IIb/IIIa appears promising. Randomized studies based on clinical staging procedures are not recommended. Survival data are promising...
  15. ncbi request reprint Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer
    C Schwarz
    Department or Pneumology II, Lungenklinik Heckeshorn Zentralklinik Emil von Behring, Germany
    Eur Respir J 24:728-30. 2004
    ..The receptor status may enable a decision on antihormonal treatment. Whether a positive receptor status in pleural metastatic tissue is associated with a better prognosis remains to be confirmed...